David Fink is a graduate of Weequahic High School (Newark, New Jersey) and received a BS in Psychology from Yale College and an MD from Harvard Medical School. Dr. Fink completed a residency in internal medicine at the Massachusetts General Hospital in Boston and a residency in neurology at the University of California, San Francisco serving as chief resident during his last year. He is Board Certified in Internal Medicine and in Neurology. Between clinical residencies he spent three years as a post-doctoral research fellow with Hal Gainer in the Laboratory of Neurochemistry at the National Institutes of Health in Bethesda.
Dr. Fink joined the Department of Neurology at the University of Michigan in 1982, moved to the University of Pittsburgh in 1994, returning to Michigan in 2004 as Chair of the Department. His research is directed at the development of gene transfer therapies for diseases of the nervous system. For this purpose his lab uses recombinant replication-defective vectors created by modification of herpes simplex virus to deliver and express transgenes in central and peripheral nervous system. Separate but related projects in chronic pain, peripheral neuropathy and spinal cord injury are each designed to develop an understanding of the molecular mechanisms of the transgene effect while moving forward towards the development of an effective human therapy.
Medical School or Training
- Harvard Medical School, 1974
- Massachusetts General Hospital, Internal Medicine, MA, 1976
- University of California, San Francisco, Neurology, CA, 1982
- Internal Medicine